v3.25.2
Earnings Per Share (EPS) (Tables)
6 Months Ended
Jun. 30, 2025
Schedule of computation of basic and diluted net loss per share attributable to common stockholders

The following table sets forth the computation of basic loss per share attributable to common stockholders and the participating securities for the periods presented (in thousands, except share and per share data):

Basic LPS:

   

Successor

   

Successor

(amounts in thousands, except share and per share data)

Three Months Ended June 30, 2025

Six Months Ended June 30, 2025

Numerator:

Net loss

$

(3,947)

$

(11,660)

Denominator:

Weighted-average shares outstanding

15,381,565

15,378,543

Net loss per share attributable to each class of participating securities – Basic

$

(0.26)

$

(0.76)

The following table sets forth the computation of diluted loss per share attributable to common stockholders for the periods presented (in thousands, except share and per share data):

Diluted LPS:

Successor

Successor

(amounts in thousands, except share and per share data)

Three Months Ended June 30, 2025

Six Months Ended June 30, 2025

Numerator:

Net loss – Basic

$

(3,947)

$

(11,660)

Less: Adjustment for fair value changes to convertible securities notes

(1,427)

(1,617)

Net loss attributable to common stockholders – Diluted

$

(5,374)

$

(13,277)

Denominator:

Weighted-average shares outstanding – Basic

15,381,565

15,378,543

Weighted-average effect of shares issuable to Convertible Securities Notes (if-converted method)

Weighted-average shares outstanding – Diluted

15,381,565

15,378,543

Net loss per share attributable to common shares – Diluted (if-converted method)

$

(0.35)

$

(0.86)

Schedule of potentially dilutive securities were excluded from the computation of diluted net loss per share

Successor

June 30, 2025

Base Warrants

7,528,727

Convert Warrants

1,500,000

Earn-out Shares, subject to vesting conditions

1,147,500

Stock options issued in connection with the Business Combination

7,587

Total potentially dilutive securities

10,183,814

Adagio Medical Inc  
Schedule of computation of basic and diluted net loss per share attributable to common stockholders

Three Months Ended June 30, 2024

   

Six Months Ended June 30, 2024

Predecessor

Predecessor

(amounts in thousands, except share and per share data)

Numerator:

Net loss attributable to common stockholders

$

(5,734)

$

(13,043)

Denominator:

Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders - basic and diluted

779,908

779,908

Net loss per share attributable to common stockholders - basic and diluted

$

(7.35)

$

(16.72)

Schedule of potentially dilutive securities were excluded from the computation of diluted net loss per share

Predecessor

   

As of June 30, 2024

Convertible preferred stock

4,732,044

Stock options

742,759

SVB Warrants

49,080

Total potentially dilutive securities

5,523,883